MX9200728A - Formulacion farmaceutica adaptada para administracformulacion farmaceutica adaptada para administracion topica, para desordenes en la piel. ion topica, para desordenes en la piel. - Google Patents
Formulacion farmaceutica adaptada para administracformulacion farmaceutica adaptada para administracion topica, para desordenes en la piel. ion topica, para desordenes en la piel.Info
- Publication number
- MX9200728A MX9200728A MX9200728A MX9200728A MX9200728A MX 9200728 A MX9200728 A MX 9200728A MX 9200728 A MX9200728 A MX 9200728A MX 9200728 A MX9200728 A MX 9200728A MX 9200728 A MX9200728 A MX 9200728A
- Authority
- MX
- Mexico
- Prior art keywords
- skin disorders
- pharmaceutical formulation
- topical
- adapted pharmaceutical
- ion
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 238000011200 topical administration Methods 0.000 title abstract 2
- 230000000699 topical effect Effects 0.000 title abstract 2
- 229960000289 fluticasone propionate Drugs 0.000 abstract 2
- WMWTYOKRWGGJOA-CENSZEJFSA-N fluticasone propionate Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(OC(=O)CC)[C@@]2(C)C[C@@H]1O WMWTYOKRWGGJOA-CENSZEJFSA-N 0.000 abstract 2
- QRJJEGAJXVEBNE-MOHJPFBDSA-N oxiconazole Chemical compound ClC1=CC(Cl)=CC=C1CO\N=C(C=1C(=CC(Cl)=CC=1)Cl)\CN1C=NC=C1 QRJJEGAJXVEBNE-MOHJPFBDSA-N 0.000 abstract 2
- 229960003483 oxiconazole Drugs 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000003937 drug carrier Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 208000017520 skin disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919103764A GB9103764D0 (en) | 1991-02-22 | 1991-02-22 | Compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9200728A true MX9200728A (es) | 1992-10-01 |
Family
ID=10690429
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9200728A MX9200728A (es) | 1991-02-22 | 1992-02-21 | Formulacion farmaceutica adaptada para administracformulacion farmaceutica adaptada para administracion topica, para desordenes en la piel. ion topica, para desordenes en la piel. |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0573492B1 (es) |
| AT (1) | ATE114244T1 (es) |
| AU (1) | AU1277792A (es) |
| CA (1) | CA2104677A1 (es) |
| DE (1) | DE69200711T2 (es) |
| DK (1) | DK0573492T3 (es) |
| ES (1) | ES2064166T3 (es) |
| GB (1) | GB9103764D0 (es) |
| GR (1) | GR3015014T3 (es) |
| MX (1) | MX9200728A (es) |
| WO (1) | WO1992014472A1 (es) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5174475A (en) * | 1991-03-26 | 1992-12-29 | Glaxo Inc. | Sequential dosing of antifungal and antiinflammatory compositions |
| GB9823036D0 (en) | 1998-10-22 | 1998-12-16 | Glaxo Group Ltd | Fluticasone lotion having improved vasoconstrictor activity |
| US6656928B1 (en) * | 1999-09-02 | 2003-12-02 | Mccadden Michael E. | Composition for the topical treatment of rashes, dermatoses and lesions |
| US6479058B1 (en) | 1999-09-02 | 2002-11-12 | Mccadden Michael E. | Composition for the topical treatment of poison ivy and other forms of contact dermatitis |
| US6858593B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| US6777400B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| GB0019172D0 (en) | 2000-08-05 | 2000-09-27 | Glaxo Group Ltd | Novel compounds |
| US6759398B2 (en) | 2000-08-05 | 2004-07-06 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative |
| US6858596B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
| US6750210B2 (en) | 2000-08-05 | 2004-06-15 | Smithkline Beecham Corporation | Formulation containing novel anti-inflammatory androstane derivative |
| US6777399B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| KR100889426B1 (ko) | 2000-08-05 | 2009-03-23 | 글락소 그룹 리미티드 | 항염증제로서의 6.알파.,9.알파.-디플루오로-17.알파.-'(2-푸라닐카르복실)옥시-11.베타.-히드록시-16.알파.-메틸-3-옥소-안드로스트-1,4-디엔-17-카르보티오산 ｓ-플루오로메틸 에스테르 |
| US6787532B2 (en) | 2000-08-05 | 2004-09-07 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivatives |
| AR032362A1 (es) * | 2000-08-14 | 2003-11-05 | Glaxo Group Ltd | Formulacion topica estable de una emulsion de aceite en agua y proceso para su preparacion |
| UA77656C2 (en) | 2001-04-07 | 2007-01-15 | Glaxo Group Ltd | S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent |
| AU2002253342B2 (en) | 2001-04-30 | 2007-01-04 | Glaxo Group Limited | Novel anti-inflammatory androstane derivatives |
| GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
| WO2012023077A1 (en) * | 2010-08-17 | 2012-02-23 | Sulur Subramaniam Vanangamudi | A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid - clobetasol propionate, and an antifungal agent - oxiconazole nitrate, and a process to make it |
-
1991
- 1991-02-22 GB GB919103764A patent/GB9103764D0/en active Pending
-
1992
- 1992-02-21 CA CA002104677A patent/CA2104677A1/en not_active Abandoned
- 1992-02-21 WO PCT/EP1992/000364 patent/WO1992014472A1/en not_active Ceased
- 1992-02-21 AU AU12777/92A patent/AU1277792A/en not_active Abandoned
- 1992-02-21 DE DE69200711T patent/DE69200711T2/de not_active Expired - Fee Related
- 1992-02-21 AT AT92905462T patent/ATE114244T1/de not_active IP Right Cessation
- 1992-02-21 DK DK92905462.5T patent/DK0573492T3/da active
- 1992-02-21 ES ES92905462T patent/ES2064166T3/es not_active Expired - Lifetime
- 1992-02-21 MX MX9200728A patent/MX9200728A/es not_active IP Right Cessation
- 1992-02-21 EP EP92905462A patent/EP0573492B1/en not_active Expired - Lifetime
-
1995
- 1995-02-08 GR GR950400256T patent/GR3015014T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU1277792A (en) | 1992-09-15 |
| ATE114244T1 (de) | 1994-12-15 |
| DE69200711T2 (de) | 1995-03-30 |
| GR3015014T3 (en) | 1995-05-31 |
| EP0573492B1 (en) | 1994-11-23 |
| DK0573492T3 (da) | 1995-01-09 |
| GB9103764D0 (en) | 1991-04-10 |
| ES2064166T3 (es) | 1995-01-16 |
| DE69200711D1 (de) | 1995-01-05 |
| WO1992014472A1 (en) | 1992-09-03 |
| EP0573492A1 (en) | 1993-12-15 |
| CA2104677A1 (en) | 1992-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9200728A (es) | Formulacion farmaceutica adaptada para administracformulacion farmaceutica adaptada para administracion topica, para desordenes en la piel. ion topica, para desordenes en la piel. | |
| IS1907B (is) | Notkun klóbindiefnisins klíókínól við að framleiða lyfjablöndu til að meðhöndla Alzheimers-sjúkdóm | |
| AU549481B2 (en) | Hair growing agent | |
| HUP0000558A3 (en) | Use of active d vitamin analogues for producing pharmaceutical composition for the treatment of prostatic diseases | |
| NO934500L (no) | Ikke-klorfluorcarbonaerosolformuleringer | |
| UY26372A1 (es) | "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen " | |
| NO994165L (no) | Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet | |
| NO951498L (no) | Farmasöytisk preparat for behandling av osteoporose | |
| EE03663B1 (et) | Rinnavähi vältimise meetod, farmatseutiline preparaat ja toode ning toimeaine kasutamine | |
| IT1290781B1 (it) | Agente attivo terapeutico per il trattamento di malattie degenerative neuronali. | |
| BR0007452A (pt) | Uso de melagatrano ou de um derivado farmaceuticamente aceitável ou pró-droga do mesmo, método de tratamento de inflamação, e, formulação farmacêutica para uso no tratamento de inflamação | |
| NO302170B1 (no) | Enantiomerisk 1-fenyl-2-(2-pyridinyl)etylamin, farmasöytisk formulering og anvendelse derav | |
| AU3401093A (en) | Therapeutic agent for threatened abortion | |
| MY110074A (en) | Pharmacuetical formulation. | |
| ZA925130B (en) | Pharmaceutical formulation. | |
| IT1224701B (it) | Preparati farmaceutici antimicrobici per applicazione topica e procedimento per la loro produzione | |
| ES2184121T3 (es) | Formulacion para el tratamiento y/o profilaxis de la demencia. | |
| NO953003L (no) | Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater | |
| SE8105500L (sv) | Psykotropa lekemedel | |
| HUP0004475A2 (hu) | Gyógyszerkészítmény | |
| IT1271354B (it) | Preparazione di una forma farmaceutica atta a combattere l'iperinsulinismo contenente n-acetil cisteine e loro analoghi | |
| IT1275987B1 (it) | Composizione farmaceutica attiva nella cura di affezioni dermatologiche | |
| NO890742D0 (no) | Farmasoeytisk preparat som sikrer den transdermale absorpsjon av aktiv bestanddel, og fremgangsmaate for fremstilling av dette. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| MM | Annulment or lapse due to non-payment of fees |